磁共振成像2024，Vol.15Issue(6)：207-211,223,6.DOI:10.12015/issn.1674-8034.2024.06.033
MRI影像组学在乳腺癌新辅助治疗疗效评价及预后的研究进展
Research progress of MRI radiomics in the efficacy evaluation and prognosis of neoadjuvant therapy for breast cancer
白颖楠 1周蓉艳 1宁子睿 1李卓琳1
作者信息
- 1. 云南省肿瘤医院(昆明医科大学第三附属医院)放射科,昆明 650118
- 折叠
摘要
Abstract
The incidence of breast cancer has jumped to the top of the global neoplastic lesions,and the incidence is still on the rise. Neoadjuvant therapy (NAT) has been widely used as the first-line treatment for patients with locally advanced breast cancer. Magnetic resonance imaging (MRI), with its good soft tissue and spatial resolution, is increasingly important in assessing lesion extent, early diagnosis, efficacy prediction, and prognostic assessment. MRI-based radiomics can analyze internal texture features that cannot be distinguished by the naked eye, which has great advantages in assessing tumor heterogeneity. Studies have demonstrated the advantages and disadvantages of MRI assessment at different time points of the NAT course in breast cancer, with multi-temporal assessment being more advantageous than single-temporal. The aim of this review is to investigate the current research status, controversies and application prospects of longitudinal temporal MRI images for evaluating neoadjuvant efficacy with the support of imaging histology, as well as the unique advantages of MRI imaging histology for predicting the long-term prognosis of neoadjuvant therapy in breast cancer patients. This study suggests the superiority of the multiseries longitudinal imaging histology model to evaluate tumor response, and provides ideas for more analysis methods of imaging histology in the future.关键词
影像组学/乳腺癌/新辅助治疗/疗效/预后/磁共振成像Key words
radiomics/breast cancer/neoadjuvant therapy/efficacy/prognosis/magnetic resonance imaging分类
医药卫生引用本文复制引用
白颖楠,周蓉艳,宁子睿,李卓琳..MRI影像组学在乳腺癌新辅助治疗疗效评价及预后的研究进展[J].磁共振成像,2024,15(6):207-211,223,6.
